FDA Adverse Event Other Summary report: N

MASIMO CORPORATION

MDR report key: 1349367 · Received March 20, 2009

Report

Report Number
2031172-2009-00003
Event Type
Other
Date Received
March 20, 2009
Date of Event
December 8, 2008
Report Date
March 10, 2009
Manufacturer
MASIMO CORPORATION
Product Code
DQA
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PER THE DIRECTIONS FOR USE (DFU) ACCOMPANIED WITH THE SENSOR MASIMO CLEARLY ALERTS THE END USER OF THE FOLLOWING: THE SITE MUST BE CHECKED AT LEAST EVERY EIGHT HOURS TO ENSURE ADEQUATE ADHESION, CIRCULATION, SKIN INTEGRITY AND CORRECT OPTICAL ALIGNMENT. CIRCULATION DISTAL TO THE SENSOR SITE SHOULD BE CHECKED ROUTINELY. EXERCISE CAUTION WITH POORLY PERFUSED PATIENTS; SKIN EROSION AND/OR PRESSURE NECROSIS MAY OCCUR. DURING LOW PERFUSION, THE SENSOR SITE NEEDS TO BE ASSESSED FREQUENTLY FOR SIGNS OF TISSUE ISCHEMIA, WHICH CAN LEAD TO PRESSURE NECROSIS. MASIMO WAS UNABLE TO OBTAIN OBJECTIVE EVIDENCE THAT THE DEVICE WAS USED IN ACCORDANCE WITH DFU.

Description of Event or Problem · 1

(B)(4). "THE PT HAD A MASIMO SET LNCS PROBE PLACED ON TOE. UPON ASSESSMENT, STAFF REPORTED SKIN BREAKDOWN. ABOUT NINE DAYS LATER, WOUND CARE NURSE REPORTED THAT ON THE UNDERSIDE OF THE LEFT BIG TOE, PT HAD SKIN BREAKDOWN WITH BURN TYPE LESION MEASURING 1.5 X .5CM. STAFF REPORT THAT THE WOUND WAS BLACKENED, NECROTIC AND UNSTAGEABLE. WOUND CARE NURSE REPORTS THAT SKIN IS HEALING AND ESCHAR IS DROPPING."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MASIMO CORPORATION ADHESIVE INFANT SPO2 SENSOR DQA MASIMO CORPORATION LNCS INFANT NA

Patients

Seq Age Sex Outcome Treatment
1 2 YR